"Диагностика и лечение на заболявания Родилна помощ; Рехабилитация; Диагностика и консултации, поискани от лекар или лекар по дентална медицина от други лечебни заведения ; Вземане и експертиза на органи (откриване, установяване на мозъчна смърт и поддържане на жизнените функции на потенциален донор с мозъчна смърт при налична сърдечна дейност) и предоставяне им за трансплантация; Вземане, съхранявана, снабдяване с кръв и кръвни съставки, трансфузионен надзор; Диспансеризация; Клинични изпитания на лекарствени продукти и медицински изделия Учебна и научна дейност"

During the past decade, MHAT - Silistra AD conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MHAT - Silistra AD" are "Colitis, Ulcerative" (2 trials), "Clostridium Difficile Infection" (1 trials), "Crohn's Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "MHAT - Silistra AD" in a lesser frequency.

Most popular intervention types in "MHAT - Silistra AD" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clostridium difficile vaccine" (1 trials), "GED-0507-34-Levo 160 mg" (1 trials), "GED-0507-34-Levo 80 mg" (1 trials) and "Placebo IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT - Silistra AD" are 4 trials for "All" genders.

Currently, there are NaN active trials in "MHAT - Silistra AD". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MHAT - Silistra AD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT - Silistra AD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".